{"name": "Cerulean Pharma",
 "permalink": "cerulean",
 "crunchbase_url": "http://www.crunchbase.com/company/cerulean",
 "homepage_url": "http://www.ceruleanrx.com/",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": 2006,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "info@Ceruleanrx.com",
 "phone_number": "617-551-9600",
 "description": "Nanobiology company",
 "created_at": "Tue Jul 28 22:22:51 UTC 2009",
 "updated_at": "Fri Mar 29 03:02:38 UTC 2013",
 "overview": "\u003Cp\u003ECerulean Pharma Inc. is a privately-held biopharmaceutical company focused on the development of novel nanotechnology-based therapeutics in the areas of oncology, cardiovascular, autoimmune and inflammatory diseases. \u003C/p\u003E\n\n\u003Cp\u003EThe Company has assembled a world-class management team, board of directors and scientific advisory board that collectively have a significant track record of business building, product development and scientific breakthroughs from companies and institutions such as Cubist, GlaxoSmithKline, Merck, Millennium Pharmaceuticals, Inc., Pfizer, Wyeth, the Massachusetts Institute of Technology, Harvard Medical School, MD Anderson, Fox Chase Cancer Center and the Arizona Health Center. \u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       46],
      "assets/images/resized/0005/4532/54532v2-max-150x150.jpg"],
     [[250,
       77],
      "assets/images/resized/0005/4532/54532v2-max-250x250.jpg"],
     [[279,
       86],
      "assets/images/resized/0005/4532/54532v2-max-450x450.jpg"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "Board Member",
    "person":
     {"first_name": "Alan",
      "last_name": "Crane",
      "permalink": "alan-crane",
      "image": null}},
   {"is_past": true,
    "title": " co-founded and served as CEO",
    "person":
     {"first_name": "Alan",
      "last_name": "Crane",
      "permalink": "alan-crane",
      "image": null}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$72.7M",
 "funding_rounds":
  [{"round_code": "b",
    "source_url": "http://www.fiercebiotech.com/story/cerulean-pockets-10m-it-catapults-clinic/2009-07-28?utm_medium=rss\u0026utm_source=rss\u0026cmp-id=OTC-RSS-FB0",
    "source_description": "Cerulean pockets $10M as it catapults into the clinic",
    "raised_amount": 10000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2009,
    "funded_month": 7,
    "funded_day": 28,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Polaris Partners",
         "permalink": "polaris-partners",
         "image":
          {"available_sizes":
            [[[150,
               36],
              "assets/images/resized/0001/1153/11153v1-max-150x150.png"],
             [[163,
               40],
              "assets/images/resized/0001/1153/11153v1-max-250x250.png"],
             [[163,
               40],
              "assets/images/resized/0001/1153/11153v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Venrock",
         "permalink": "venrock",
         "image":
          {"available_sizes":
            [[[150,
               52],
              "assets/images/resized/0001/6279/16279v1-max-150x150.jpg"],
             [[250,
               87],
              "assets/images/resized/0001/6279/16279v1-max-250x250.jpg"],
             [[351,
               123],
              "assets/images/resized/0001/6279/16279v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Lux Capital",
         "permalink": "lux-capital",
         "image":
          {"available_sizes":
            [[[150,
               54],
              "assets/images/resized/0004/3976/43976v1-max-150x150.png"],
             [[250,
               90],
              "assets/images/resized/0004/3976/43976v1-max-250x250.png"],
             [[261,
               94],
              "assets/images/resized/0004/3976/43976v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Bessemer Venture Partners",
         "permalink": "bessemer-venture-partners",
         "image":
          {"available_sizes":
            [[[150,
               33],
              "assets/images/resized/0001/3853/13853v2-max-150x150.png"],
             [[250,
               56],
              "assets/images/resized/0001/3853/13853v2-max-250x250.png"],
             [[336,
               76],
              "assets/images/resized/0001/3853/13853v2-max-450x450.png"]],
           "attribution": null}},
       "person": null}]},
   {"round_code": "b",
    "source_url": "http://ceruleanrx.com/Press/CeruleanPressRelease_010308.pdf",
    "source_description": "Tempo Pharmaceuticals Closes $8 Million in Series B Funding",
    "raised_amount": 8100000.0,
    "raised_currency_code": "USD",
    "funded_year": 2008,
    "funded_month": 1,
    "funded_day": 3,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Polaris Partners",
         "permalink": "polaris-partners",
         "image":
          {"available_sizes":
            [[[150,
               36],
              "assets/images/resized/0001/1153/11153v1-max-150x150.png"],
             [[163,
               40],
              "assets/images/resized/0001/1153/11153v1-max-250x250.png"],
             [[163,
               40],
              "assets/images/resized/0001/1153/11153v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Venrock",
         "permalink": "venrock",
         "image":
          {"available_sizes":
            [[[150,
               52],
              "assets/images/resized/0001/6279/16279v1-max-150x150.jpg"],
             [[250,
               87],
              "assets/images/resized/0001/6279/16279v1-max-250x250.jpg"],
             [[351,
               123],
              "assets/images/resized/0001/6279/16279v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Lux Capital",
         "permalink": "lux-capital",
         "image":
          {"available_sizes":
            [[[150,
               54],
              "assets/images/resized/0004/3976/43976v1-max-150x150.png"],
             [[250,
               90],
              "assets/images/resized/0004/3976/43976v1-max-250x250.png"],
             [[261,
               94],
              "assets/images/resized/0004/3976/43976v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Bessemer Venture Partners",
         "permalink": "bessemer-venture-partners",
         "image":
          {"available_sizes":
            [[[150,
               33],
              "assets/images/resized/0001/3853/13853v2-max-150x150.png"],
             [[250,
               56],
              "assets/images/resized/0001/3853/13853v2-max-250x250.png"],
             [[336,
               76],
              "assets/images/resized/0001/3853/13853v2-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Alexandria Real Estate Equities",
         "permalink": "alexandria-real-estate-equities",
         "image":
          {"available_sizes":
            [[[150,
               52],
              "assets/images/resized/0005/2582/52582v2-max-150x150.jpg"],
             [[235,
               82],
              "assets/images/resized/0005/2582/52582v2-max-250x250.jpg"],
             [[235,
               82],
              "assets/images/resized/0005/2582/52582v2-max-450x450.jpg"]],
           "attribution": null}},
       "person": null}]},
   {"round_code": "a",
    "source_url": "http://ceruleanrx.com/Press/CeruleanPressRelease_052307.pdf",
    "source_description": "Tempo Pharmaceuticals Closes $12.1 Million in Series A Funding",
    "raised_amount": 12100000.0,
    "raised_currency_code": "USD",
    "funded_year": 2007,
    "funded_month": 5,
    "funded_day": 23,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Venrock",
         "permalink": "venrock",
         "image":
          {"available_sizes":
            [[[150,
               52],
              "assets/images/resized/0001/6279/16279v1-max-150x150.jpg"],
             [[250,
               87],
              "assets/images/resized/0001/6279/16279v1-max-250x250.jpg"],
             [[351,
               123],
              "assets/images/resized/0001/6279/16279v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Polaris Partners",
         "permalink": "polaris-partners",
         "image":
          {"available_sizes":
            [[[150,
               36],
              "assets/images/resized/0001/1153/11153v1-max-150x150.png"],
             [[163,
               40],
              "assets/images/resized/0001/1153/11153v1-max-250x250.png"],
             [[163,
               40],
              "assets/images/resized/0001/1153/11153v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Lux Capital",
         "permalink": "lux-capital",
         "image":
          {"available_sizes":
            [[[150,
               54],
              "assets/images/resized/0004/3976/43976v1-max-150x150.png"],
             [[250,
               90],
              "assets/images/resized/0004/3976/43976v1-max-250x250.png"],
             [[261,
               94],
              "assets/images/resized/0004/3976/43976v1-max-450x450.png"]],
           "attribution": null}},
       "person": null}]},
   {"round_code": "unattributed",
    "source_url": "",
    "source_description": "EDGAR",
    "raised_amount": 2000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2006,
    "funded_month": 12,
    "funded_day": 1,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Polaris Partners",
         "permalink": "polaris-partners",
         "image":
          {"available_sizes":
            [[[150,
               36],
              "assets/images/resized/0001/1153/11153v1-max-150x150.png"],
             [[163,
               40],
              "assets/images/resized/0001/1153/11153v1-max-250x250.png"],
             [[163,
               40],
              "assets/images/resized/0001/1153/11153v1-max-450x450.png"]],
           "attribution": null}},
       "person": null}]},
   {"round_code": "unattributed",
    "source_url": "http://www.masshightech.com/stories/2010/10/11/daily100-Cerulean-Pharma-raises-15M-financing.html",
    "source_description": "Cerulean Pharma raises $1.5M financing",
    "raised_amount": 1500000.0,
    "raised_currency_code": "USD",
    "funded_year": 2010,
    "funded_month": 10,
    "funded_day": 14,
    "investments":
     []},
   {"round_code": "c",
    "source_url": "http://www.finsmes.com/2010/11/cerulean-pharma-closes-24m-series-c.html",
    "source_description": "Cerulean Pharma Closes $24M Series C Financing",
    "raised_amount": 24000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2010,
    "funded_month": 11,
    "funded_day": 15,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Lilly Ventures",
         "permalink": "lilly-ventures",
         "image":
          {"available_sizes":
            [[[150,
               71],
              "assets/images/resized/0005/5135/55135v3-max-150x150.png"],
             [[240,
               114],
              "assets/images/resized/0005/5135/55135v3-max-250x250.png"],
             [[240,
               114],
              "assets/images/resized/0005/5135/55135v3-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Polaris Partners",
         "permalink": "polaris-partners",
         "image":
          {"available_sizes":
            [[[150,
               36],
              "assets/images/resized/0001/1153/11153v1-max-150x150.png"],
             [[163,
               40],
              "assets/images/resized/0001/1153/11153v1-max-250x250.png"],
             [[163,
               40],
              "assets/images/resized/0001/1153/11153v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Venrock",
         "permalink": "venrock",
         "image":
          {"available_sizes":
            [[[150,
               52],
              "assets/images/resized/0001/6279/16279v1-max-150x150.jpg"],
             [[250,
               87],
              "assets/images/resized/0001/6279/16279v1-max-250x250.jpg"],
             [[351,
               123],
              "assets/images/resized/0001/6279/16279v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Lux Capital",
         "permalink": "lux-capital",
         "image":
          {"available_sizes":
            [[[150,
               54],
              "assets/images/resized/0004/3976/43976v1-max-150x150.png"],
             [[250,
               90],
              "assets/images/resized/0004/3976/43976v1-max-250x250.png"],
             [[261,
               94],
              "assets/images/resized/0004/3976/43976v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Bessemer Venture Partners",
         "permalink": "bessemer-venture-partners",
         "image":
          {"available_sizes":
            [[[150,
               33],
              "assets/images/resized/0001/3853/13853v2-max-150x150.png"],
             [[250,
               56],
              "assets/images/resized/0001/3853/13853v2-max-250x250.png"],
             [[336,
               76],
              "assets/images/resized/0001/3853/13853v2-max-450x450.png"]],
           "attribution": null}},
       "person": null}]},
   {"round_code": "d",
    "source_url": "http://www.finsmes.com/2011/12/cerulean-pharma-closes-15m-series-financing.html?utm_source=feedburner\u0026utm_medium=feed\u0026utm_campaign=Feed%3A+finsmes%2FcNHu+%28FinSMEs%29",
    "source_description": "Cerulean Pharma Closes $15m Series D Financing",
    "raised_amount": 15000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2011,
    "funded_month": 12,
    "funded_day": 15,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Polaris Partners",
         "permalink": "polaris-partners",
         "image":
          {"available_sizes":
            [[[150,
               36],
              "assets/images/resized/0001/1153/11153v1-max-150x150.png"],
             [[163,
               40],
              "assets/images/resized/0001/1153/11153v1-max-250x250.png"],
             [[163,
               40],
              "assets/images/resized/0001/1153/11153v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Venrock",
         "permalink": "venrock",
         "image":
          {"available_sizes":
            [[[150,
               52],
              "assets/images/resized/0001/6279/16279v1-max-150x150.jpg"],
             [[250,
               87],
              "assets/images/resized/0001/6279/16279v1-max-250x250.jpg"],
             [[351,
               123],
              "assets/images/resized/0001/6279/16279v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Lilly Ventures",
         "permalink": "lilly-ventures",
         "image":
          {"available_sizes":
            [[[150,
               71],
              "assets/images/resized/0005/5135/55135v3-max-150x150.png"],
             [[240,
               114],
              "assets/images/resized/0005/5135/55135v3-max-250x250.png"],
             [[240,
               114],
              "assets/images/resized/0005/5135/55135v3-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Lux Capital",
         "permalink": "lux-capital",
         "image":
          {"available_sizes":
            [[[150,
               54],
              "assets/images/resized/0004/3976/43976v1-max-150x150.png"],
             [[250,
               90],
              "assets/images/resized/0004/3976/43976v1-max-250x250.png"],
             [[261,
               94],
              "assets/images/resized/0004/3976/43976v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Bessemer Venture Partners",
         "permalink": "bessemer-venture-partners",
         "image":
          {"available_sizes":
            [[[150,
               33],
              "assets/images/resized/0001/3853/13853v2-max-150x150.png"],
             [[250,
               56],
              "assets/images/resized/0001/3853/13853v2-max-250x250.png"],
             [[336,
               76],
              "assets/images/resized/0001/3853/13853v2-max-450x450.png"]],
           "attribution": null}},
       "person": null}]}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": " 161 First Street",
    "address2": "",
    "zip_code": "02142",
    "city": "Cambridge",
    "state_code": "MA",
    "country_code": "USA",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [{"description": "has closed a $24 million Series C financing led by Lilly Ventures, and named Steve Hall, a venture partner at Lilly Ventures, to the company\u00e2\u20ac\u2122s board.",
    "stoned_year": 2010,
    "stoned_month": 11,
    "stoned_day": 15,
    "source_url": "http://www.masshightech.com/stories/2010/11/15/daily2-Cerulean-Pharma-pins-down-24M-in-Series-C-funding.html",
    "source_text": null,
    "source_description": "Cerulean Pharma pins down $24M in Series C funding",
    "stoneable_type": "Company",
    "stoned_value": null,
    "stoned_value_type": null,
    "stoned_acquirer": null,
    "stoneable":
     {"name": "Cerulean Pharma",
      "permalink": "cerulean"}}],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [{"available_sizes":
     [[[150,
        102],
       "assets/images/resized/0007/0425/70425v1-max-150x150.jpg"],
      [[250,
        170],
       "assets/images/resized/0007/0425/70425v1-max-250x250.jpg"],
      [[450,
        306],
       "assets/images/resized/0007/0425/70425v1-max-450x450.jpg"]],
    "attribution": null}],
 "external_links":
  []}